172 related articles for article (PubMed ID: 1438532)
1. Ornithine decarboxylase as an enzyme target for therapy.
McCann PP; Pegg AE
Pharmacol Ther; 1992; 54(2):195-215. PubMed ID: 1438532
[TBL] [Abstract][Full Text] [Related]
2. Ornithine decarboxylase in Pneumocystis carinii and implications for therapy.
Sarić M; Clarkson AB
Antimicrob Agents Chemother; 1994 Nov; 38(11):2545-52. PubMed ID: 7872745
[TBL] [Abstract][Full Text] [Related]
3. Involvement of antizyme in stabilization of ornithine decarboxylase caused by inhibitors of polyamine synthesis.
Murakami Y; Nishiyama M; Hayashi S
Eur J Biochem; 1989 Mar; 180(1):181-4. PubMed ID: 2495941
[TBL] [Abstract][Full Text] [Related]
4. [DFMO: an alternative therapeutic agent for human African trypanosomiasis].
Breton JC; Bouteille B; Sonan T
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):571-7. PubMed ID: 3143490
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into DFMO resistant ornithine decarboxylase from Entamoeba histolytica: an inkling to adaptive evolution.
Preeti ; Tapas S; Kumar P; Madhubala R; Tomar S
PLoS One; 2013; 8(1):e53397. PubMed ID: 23326423
[TBL] [Abstract][Full Text] [Related]
6. Studies on the effects of an ornithine decarboxylase inhibitor on lupus nephritis reveal a post-transcriptional modification of the enzyme.
Hsu HC; Thomas T; Seibold JR; Thomas TJ
Agents Actions; 1993; 39 Spec No():C204-6. PubMed ID: 8273569
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of renal ornithine decarboxylase activity fails to reduce kidney size and urinary albumin excretion in diabetic rats with manifest kidney hypertrophy.
Pedersen SB; Bjørn SF; Richelsen B; Flyvbjerg A
Mol Cell Endocrinol; 1995 Jan; 107(1):123-8. PubMed ID: 7796931
[TBL] [Abstract][Full Text] [Related]
8. Polyamine metabolism in Pneumocystis carinii.
Lipschik GY; Masur H; Kovacs JA
J Infect Dis; 1991 May; 163(5):1121-7. PubMed ID: 2019760
[TBL] [Abstract][Full Text] [Related]
9. Virtual screening of natural inhibitors targeting ornithine decarboxylase with pharmacophore scaffolding of DFMO and validation by molecular dynamics simulation studies.
Sivashanmugam M; K N S; V U
J Biomol Struct Dyn; 2019 Feb; 37(3):766-780. PubMed ID: 29436980
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine in African trypanosomes and Pneumocystis carinii as a basis of chemotherapy: biochemical and clinical aspects.
McCann PP; Bacchi CJ; Clarkson AB; Bey P; Sjoerdsma A; Schecter PJ; Walzer PD; Barlow JL
Am J Trop Med Hyg; 1986 Nov; 35(6):1153-6. PubMed ID: 3098121
[TBL] [Abstract][Full Text] [Related]
11. Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells.
Manni A; Wechter R; Gilmour S; Verderame MF; Mauger D; Demers LM
Int J Cancer; 1997 Jan; 70(2):175-82. PubMed ID: 9009157
[TBL] [Abstract][Full Text] [Related]
12. On the translational control of ornithine decarboxylase expression by polyamines.
Stjernborg L; Heby O; Holm I; Persson L
Biochim Biophys Acta; 1991 Oct; 1090(2):188-94. PubMed ID: 1932110
[TBL] [Abstract][Full Text] [Related]
13. Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential.
Shantz LM; Levin VA
Amino Acids; 2007 Aug; 33(2):213-23. PubMed ID: 17443268
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
[TBL] [Abstract][Full Text] [Related]
15. Ornithine uptake and the modulation of drug sensitivity in
Macedo JP; Currier RB; Wirdnam C; Horn D; Alsford S; Rentsch D
FASEB J; 2017 Oct; 31(10):4649-4660. PubMed ID: 28679527
[No Abstract] [Full Text] [Related]
16. A unified pathway for the degradation of ornithine decarboxylase in reticulocyte lysate requires interaction with the polyamine-induced protein, ornithine decarboxylase antizyme.
Mamroud-Kidron E; Omer-Itsicovich M; Bercovich Z; Tobias KE; Rom E; Kahana C
Eur J Biochem; 1994 Dec; 226(2):547-54. PubMed ID: 8001569
[TBL] [Abstract][Full Text] [Related]
17. Thrombin stimulates vascular smooth muscle cell polyamine synthesis by inducing cationic amino acid transporter and ornithine decarboxylase gene expression.
Durante W; Liao L; Peyton KJ; Schafer AI
Circ Res; 1998 Jul; 83(2):217-23. PubMed ID: 9686762
[TBL] [Abstract][Full Text] [Related]
18. No role of the 5' untranslated region of ornithine decarboxylase mRNA in the feedback control of the enzyme.
Wallström EL; Persson L
Mol Cell Biochem; 1999 Jul; 197(1-2):71-8. PubMed ID: 10485326
[TBL] [Abstract][Full Text] [Related]
19. Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity.
Kim DJ; Roh E; Lee MH; Oi N; Lim DY; Kim MO; Cho YY; Pugliese A; Shim JH; Chen H; Cho EJ; Kim JE; Kang SC; Paul S; Kang HE; Jung JW; Lee SY; Kim SH; Reddy K; Yeom YI; Bode AM; Dong Z
Cancer Res; 2016 Mar; 76(5):1146-1157. PubMed ID: 26676750
[TBL] [Abstract][Full Text] [Related]
20. Polyamine metabolism: a potential therapeutic target in trypanosomes.
Bacchi CJ; Nathan HC; Hutner SH; McCann PP; Sjoerdsma A
Science; 1980 Oct; 210(4467):332-4. PubMed ID: 6775372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
